BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8132349)

  • 1. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
    Cripps AW; Dunkley ML; Clancy RL
    Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
    Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
    Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung.
    Thomas LD; Dunkley ML; Moore R; Reynolds S; Bastin DA; Kyd JM; Cripps AW
    Vaccine; 2000 Sep; 19(2-3):348-57. PubMed ID: 10930690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.
    Buret A; Dunkley ML; Pang G; Clancy RL; Cripps AW
    Infect Immun; 1994 Dec; 62(12):5335-43. PubMed ID: 7960112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model.
    Kyd JM; Dunkley ML; Cripps AW
    Infect Immun; 1995 Aug; 63(8):2931-40. PubMed ID: 7622215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to Pseudomonas aeruginosa induced by OprF following intestinal immunization.
    Cripps AW; Dunkley ML; Taylor DC; Cousins S; Clancy RL
    Adv Exp Med Biol; 1995; 371B():761-3. PubMed ID: 7502893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local immunization against P. aeruginosa with an outer-membrane-protein vaccine].
    Grundmann T; Freihorst J; Kubesch P; Tümmler B; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):924-7. PubMed ID: 1763004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis.
    Kyd J; John A; Cripps A; Murphy TF
    Vaccine; 1999 Oct; 18(5-6):398-406. PubMed ID: 10519928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
    Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of the lung following intratracheal challenge with live Pseudomonas aeruginosa in intestinally immunized rats.
    Wilson NR; Dunkley ML; Buret A; Young B; Cripps AW
    Immunol Cell Biol; 1995 Oct; 73(5):440-5. PubMed ID: 8595922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective role of pulmonary neutrophils in rats intestinally immunized with Pseudomonas aeruginosa.
    Buret A; Dunkley M; Clancy RL; Cripps AW
    Adv Exp Med Biol; 1995; 371B():765-9. PubMed ID: 7502894
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
    Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
    Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to respiratory Pseudomonas aeruginosa infection: P. aeruginosa-specific T cells arising after intestinal immunization.
    Dunkley ML; Cripps AW; Clancy RL
    Adv Exp Med Biol; 1995; 371B():755-9. PubMed ID: 7502892
    [No Abstract]   [Full Text] [Related]  

  • 17. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
    Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa.
    Thomas LD; Kyd JM; Bastin DA; Dunkley ML; Cripps AW
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):155-60. PubMed ID: 12832119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.